News

OpenAI declined to comment, while Windsurf, formerly known as Codeium, did not immediately respond to a Reuters request for ...
This study presents an innovative approach to single-atom catalysts, overcoming oxidative addition challenges in cross-coupling reactions for pharmaceuticals.
The fossil fuel industry is pushing Congress for immunity from climate lawsuits that could force the industry to pay billions for misleading the public about the dangers of fossil fuels — attempting ...
Donald Trump’s erratic tariff rollout seems likely to deepen the world’s dependence on China and scare off investment in US ...
Shares of Catalyst Pharmaceuticals Inc. CPRX rallied 2.80% to $22.05 Friday, on what proved to be an all-around positive ...
We recently published a list of 11 Best Russell 2000 Stocks to Buy According to Wall Street Analysts. In this article, we are ...
Anthropic, the US AI company behind the Claude chatbot, said it would create more than 100 roles in Europe, including in ...
Kye Pharmaceuticals announced it has submitted a New Drug Submission, or NDS, to Health Canada for the regulatory review and approval of ...
A new light-activated catalyst breaks and resets carbon–halogen bonds to convert racemic mixtures into enantiomerically ...
Biotech companies create drugs from living organisms, requiring a BLA for FDA approval. Pharma companies develop drugs from chemicals, needing an NDA for FDA approval. Many firms blend biotech and ...
Homogeneous catalysis is a type of catalysis in which the catalyst operates in the same phase as the reactants — usually dissolved in a solvent. Mechanistic studies of homogeneous catalysts are ...